Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | -4.04% | +25.00% | -30.32% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Financials (USD)
Sales 2024 * | 456M | Sales 2025 * | 477M | Capitalization | 378M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 7M | EV / Sales 2024 * | 0.81 x |
Net cash position 2024 * | 9.83M | Net cash position 2025 * | 24.56M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
-285
x | P/E ratio 2025 * |
53.4
x | Employees | 862 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
Latest transcript on Organogenesis Holdings Inc.
1 day | -4.04% | ||
1 week | +25.00% | ||
Current month | +21.28% | ||
1 month | -0.35% | ||
3 months | -18.10% | ||
6 months | +12.65% | ||
Current year | -30.32% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Gillheeney
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Francisco
DFI | Director of Finance/CFO | 59 | 21-02-15 |
Patrick Bilbo
COO | Chief Operating Officer | 63 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Nussdorf
BRD | Director/Board Member | 70 | 02-12-31 |
Alan Ades
BRD | Director/Board Member | 86 | 02-12-31 |
Michael Driscoll
BRD | Director/Board Member | 63 | 22-02-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 25 M€ | -1.18% | - | |
0.09% | 28 M€ | -0.39% | ||
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 2.85 | -4.04% | 554,237 |
24-05-15 | 2.97 | +4.39% | 579,261 |
24-05-14 | 2.845 | -3.89% | 1,510,615 |
24-05-13 | 2.96 | -2.31% | 2,976,661 |
24-05-10 | 3.03 | +32.89% | 3,551,467 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.32% | 378M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.28% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- ORGO Stock